Search alternatives:
reduction » education (Expand Search)
Showing 181 - 200 results of 1,222 for search 'Metabolic function reduction', query time: 0.13s Refine Results
  1. 181

    KDDC: a new framework that integrates kmers, dataset filtering, dimension reduction and classification algorithms to achieve immune cell heterogeneity classification by Nan Zhang, Nan Zhang, Shishun Zhao, Runze Wu, Xizi Luo, Ming Yang, Zecheng Chang, Jianting Xu

    Published 2025-05-01
    “…We also observed that 11 distinct cell subpopulations exhibited differences in cell proportions, inflammatory factorexpression, cell communication, and metabolic pathways, with notable activity in metabolic pathways. …”
    Get full text
    Article
  2. 182
  3. 183

    Study on the function of TTG1 gene in Camellia oleifera by Chengcheng Xiang, Chengcheng Xiang, Lizhi Xiao, Lizhi Xiao, Hongmei Tao, Hongmei Tao, Jie Cao, Jie Cao, Jun Yuan, Jun Yuan, Weihao Wang, Yao Jiang, Yao Jiang

    Published 2025-08-01
    “…Although the WD40-repeat transcription factor TTG1 is known to regulate plant secondary metabolism and development, its specific functions in C. oleifera remain uncharacterized. …”
    Get full text
    Article
  4. 184

    Novel use of proton magnetic resonance spectroscopy (1HMRS) to non-invasively assess placental metabolism. by Fiona C Denison, Scott I Semple, Sarah J Stock, Jane Walker, Ian Marshall, Jane E Norman

    Published 2012-01-01
    “…Proton magnetic resonance spectroscopy ((1)H MRS) can be used to assess the metabolic profile of tissue in-vivo. In FGR pregnancies, a reduction in N-acetylaspartate (NAA)/choline ratio and detection of lactate methyl are emerging as biomarkers of impaired neuronal metabolism and fetal hypoxia, respectively. …”
    Get full text
    Article
  5. 185

    Therapeutic effects of metabolic cardioprotector containing L-arginine and inosine in elderly patients with ischemic heart disease by O. A. Vorobjova

    Published 2012-08-01
    “…Recovery of endothelium-depended vasodilatation, improvement of indexes of nitric oxide metabolism, oxidative stress reduction, decrease of duration and expressiveness of episodes of myocardial ischemia during treatment by metabolic cardioprotector as a part of complex therapy throughout 3 months in these patients were shown.…”
    Get full text
    Article
  6. 186

    Reduced removal of waste products from energy metabolism takes center stage in human brain aging by Silvia Mangia, Mauro DiNuzzo, Sara Ponticorvo, Gerald A. Dienel, Kevin L. Behar, Helene Benveniste, Fahmeed Hyder, Federico Giove, Suzana Herculano-Houzel, Ognen A. Petroff, Lynn E. Eberly, Pavel Filip, Shalom Michaeli, Douglas L. Rothman

    Published 2025-03-01
    “…However, CBF is required also to clear the byproducts of energy metabolism, namely CO2 and protons. With the goal of determining whether age-associated reduction in regional CBF may lead to abnormal brain partial pressure of carbon dioxide (pCO2) and pH levels that are sufficient to alter brain activity and cognitive function, we applied a recently introduced homeostatic modeling of nutrients and waste products to human neuroimaging PET data acquired in young and older adults (Goyal et al. in Cell Metab 26(2):353–360, 2017). …”
    Get full text
    Article
  7. 187
  8. 188

    ROLE OF GENETIC VARIABILITY IN METABOLIC PATHWAYS ON CISPLATIN-INDUCED KIDNEY INJURY IN HEAD AND NECK CANCER PATIENTS by Ericka Francislaine Dias Costa, Ana Maria Castro Ferreira, Marilda Mazzali, Gustavo Jacob Lourenço, Carmen Silvia Passos Lima

    Published 2025-05-01
    “…Patients with the GSTP1 c.313AG or GG and ERCC1 c.354CT or TTC>T (17.57%), MLH1 c.93GA or A (12.49%), or MSH3 c.3133AG or GG (12.19%) combined genotypes showed a reduction in renal function after CDDP treatment. Renal function declines of 18.85% and 13.38% were observed in patients with ERCC1 c.354CT or TT and MLH1 c.93GA or AA or MSH3 c.3133AG or GG combined genotypes, respectively. …”
    Get full text
    Article
  9. 189
  10. 190

    Effects and mechanisms of phytochemicals on skeletal muscle atrophy in glucolipid metabolic disorders: current evidence and future perspectives by Mengjie Li, Yige Qin, Ruixuan Geng, Jingjing Fang, Seong-Gook Kang, Kunlun Huang, Tao Tong

    Published 2025-01-01
    “…Several studies demonstrated an inverse relationship between dietary phytochemical supplementation and the onset of skeletal muscle atrophy caused by glucolipid metabolic disorders, as evidenced by improved muscle quality and function. …”
    Get full text
    Article
  11. 191

    The Hepatoprotective Properties of Gentiopicroside, Sweroside, and Swertiamarin Against Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Anthony O. Boateng, Vinood B. Patel, S. W. Annie Bligh

    Published 2025-05-01
    “…Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disease characterised by the accumulation of fat in the liver. …”
    Get full text
    Article
  12. 192
  13. 193

    Hypoxia Dependent Inhibition of Glioblastoma Cell Proliferation, Invasion, and Metabolism by the Choline-Kinase Inhibitor JAS239 by Claire Louise Kelly, Martyna Wydrzynska, Marie M. Phelan, Sofya Osharovich, Edward J. Delikatny, Violaine Sée, Harish Poptani

    Published 2025-01-01
    “…In addition, cell proliferation, cell cycle progression, and cell invasion parameters were measured in 2D cell monolayers as well as in 3D cell spheroids, with or without JAS239 treatment, in normoxic or hypoxic cells to assess the effect of hypoxia on JAS239 function. <b>Results:</b> Hypoxia and JAS239 treatment led to significant changes in the cellular metabolic pathways, specifically the phospholipid and glycolytic pathways, associated with a reduction in cell proliferation via induced cell cycle arrest. …”
    Get full text
    Article
  14. 194

    Mechanisms of Cisplatin-Induced Acute Kidney Injury: The Role of NRF2 in Mitochondrial Dysfunction and Metabolic Reprogramming by Jihan Liu, Yiming Wang, Panshuang Qiao, Yi Ying, Simei Lin, Feng Lu, Cai Gao, Min Li, Baoxue Yang, Hong Zhou

    Published 2025-06-01
    “…<i>Nfe2l2</i> knockout mice showed aggravated kidney injury, characterized by worsened kidney function and histopathological damage. Mechanistically, <i>Nfe2l2</i> knockout resulted in redox imbalance, reduced ATP synthesis, mitochondrial dysfunction and metabolic dysregulation. …”
    Get full text
    Article
  15. 195

    CNOT6L regulates energy metabolism in the ovarian granulosa cells associated with polycystic ovary syndrome by Shan Han, Shan Han, Yanqiu Xie, Jiale Lv, Xuedong Sun, Yuhua Shi, Yuhua Shi, Yuhua Shi

    Published 2025-05-01
    “…Subsequently, we conducted the Cnot6l-overexpressed granulosa cells to explore the alterations by which CNOT6L regulates ovarian granulosa cell function. The overexpression of CNOT6L in granulosa cells significantly inhibited the glycolytic pathway, activated the mitochondrial oxidative phosphorylation pathway, led to a reduction in the generation of the intermediate product lactate, and resulted in impaired energy supply to the oocyte. …”
    Get full text
    Article
  16. 196
  17. 197
  18. 198
  19. 199

    Testosterone Deficiency and Lipid Dysregulation in Individuals with Coexisting Hypothyroidism and Type 2 Diabetes: Clinical and Metabolic Implications by Mandayal Jamatia, Mohammad N Khan, Ashok Kumar

    Published 2025-05-01
    “…Aim and background: This study aims to evaluate the biochemical and endocrine changes in individuals with diabetes, hypothyroidism, and their coexistence, focusing on glycemic control, lipid metabolism, and hormonal balance. Understanding their interplay is crucial for optimizing disease management, enabling early intervention, and improving patient outcomes through personalized therapeutic strategies and risk reduction approaches. …”
    Get full text
    Article
  20. 200

    The effects of HAPA theory-based case management in patients with metabolic dysfunction-associated steatotic liver disease by Jia Mei, Yuncai Xie, Pingping Huang, Yudi Jin, Xia Wang, Ying Chen

    Published 2025-07-01
    “…Introduction and Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease affecting people's health, with its incidence increasing year by year. …”
    Get full text
    Article